Random non-fasting C-peptide: bringing robust assessment of endogenous insulin secretion to the clinic.

Abstract

Measuring endogenous insulin secretion using C-peptide can assist diabetes management, but standard stimulation tests are impractical for clinical use. Random non-fasting C-peptide assessment would allow testing when a patient is seen in clinic.